4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001193125-26-021378
Chief Financial Officer sold 12,000 shares at $187.92 ($2,255,040)
- Chief Financial Officer acquired 12,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Pizzie Nick · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-22 | Exercise or conversion : show line 1 in the form 10b5-1 | +12,000 | $3.50 | $42,000 | 54,588 | D |
| 2026-01-22 | Sale : show line 2 in the form 10b5-1 | −12,000 | $187.92 | $2,255,040 | 42,588 | D |
| Open-market sales · 12,000 sh · avg $187.92 · $2,255,040 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-22 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −12,000 | 105,000 | D |
Loading xslF345X05/ownership.xml…